Topic suspended
Status Suspended
Process STA pre-2018
ID number 929

Project Team

Project lead Stephanie Callaghan

Email enquiries


Key events during the development of the guidance:

Date Update
27 September 2018 Suspended, Topic suspended
11 October 2016 The Department of Health has asked us to carry out a Single Technology Appraisal (STA) of Dabrafenib with trametinib within its marketing authorisation for treating advanced, metastatic BRAF V600E mutation-positive non-small-cell lung cancer Further information regarding the timelines for this appraisal will be available in due course.
22 July 2016 Referral

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance